5 news items
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ADPT
ADSK
ALXO
17 Apr 24
analyst Hartaj Singh maintained Viracta Therapeutics with an Outperform and maintained a $13 price target.
Spectaire Holdings Inc
Portage Biotech Announces Plans To Expand Its Evaluation Of Strategic Alternatives To Extend Its Available Cash Runway
PRTG
12 Apr 24
company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it is expanding its evaluation of strategic
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
PRTG
12 Apr 24
immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it is expanding its
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
INTS
PRTG
26 Mar 24
-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it has completed
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
ACMR
AFIB
ALHC
19 Mar 24
Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21.
SCWorx Corp
- Prev
- 1
- Next